Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
Global Sports Medicine Market Report: 2014 Edition
By Koncept Analytics
Orthopedics is defined as the study of human musculoskeletal system. It is basically a branch of medical sciences dealing with the prevention and correction of injuries or disorders of the skeletal system and associated muscles, joints, and ligame...
Oct 2014 $ 800
Sri Lanka Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Sri Lanka's pharmaceutical sector has received investment from domestic and foreign - notably Indian - investors in recent years, as economic growth has picked up and the government focused on improving the domestic pharmaceutic...
Oct 2014 $ 1295
Moldova Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: The Moldovan pharmaceutical market presents limited opportunities for investors, given the market's total size and its reliance on out-of-pocket payments. The country's economic outlook, which is defined by its relations with Ru...
Oct 2014 $ 1295
Egypt Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Egypt's relative political stability will lead to a pickup in growth over the coming quarters, increasing the attractiveness of the pharmaceutical market - for which our forecast has been revised slightly upwards. The government...
Oct 2014 $ 1295
Global Non-Invasive Prenatal Testing Market, Test Volume & Forecast
By Renub Research
The development of the non–invasive prenatal test (NIPT) has transformed the prenatal testing market. NIPT has the potential to drastically change how pregnancies are managed. Non–invasive prenatal genetic testing (NIPT) has been comme...
Oct 2014 $ 1400
Solarrus Corporation Acquires MaxGen Energy Services from Signal Energy Constructors - Deal Analysis from GlobalData
By GlobalData
Solarrus Corporation Acquires MaxGen Energy Services from Signal Energy Constructors - Deal Analysis from GlobalData Summary Solarrus Corporation (Solarrus), an alternative energy services company, has acquired MaxGen En...
Oct 2014 $ 500
Direct Energy Services Acquires Astrum Solar - Deal Analysis from GlobalData
By GlobalData
Direct Energy Services Acquires Astrum Solar - Deal Analysis from GlobalData Summary Direct Energy Services (DES), an integrated energy company and a subsidiary of Centrica, has acquired Astrum Solar (Astrum), a provider...
Oct 2014 $ 500
Venezuela Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Venezuela's improving foreign currency supply, increasing pharmaceutical imports from political allies and the potential expansion of free medicine coverage in the public sector will ease the shortage of local medicines in the n...
Oct 2014 $ 1295
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescription numbers, does not come as a surprise and is expected to continue beyond 2014. This drop in spending reflects the UK government's focus on...
Oct 2014 $ 1295
Switzerland Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increased pharmaceutical and healthcare spending. The proportion of the pensionable population is high and growing, and this will translate into gr...
Oct 2014 $ 1295
Qatar Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: The reduction of a large number of medicine prices in Qatar is likely to be detrimental to pharmaceutical companies' revenue potential. New drug pricing - which was previously very high in the country - will increase the volume ...
Oct 2014 $ 1295
Portugal Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Despite Portugal's stronger-than-expected economic expansion in previous quarters, government austerity measures will continue to weigh on drug spending over the medium term. This is reflected in recent agreements between the Po...
Oct 2014 $ 1295
Morocco Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: As Morocco's economic conditions improve towards the end of 2014 and the rate of decline in pharmaceutical sales slows, we hold an overall positive outlook for the market over the medium-to-long term, which will be driven by the...
Oct 2014 $ 1295
Lithuania Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Collective procurement of medicines with Latvia and Estonia will benefit the development of the pharmaceutical market, albeit at the cost of pricing cuts. While these markets are singularly small, together they represent an attr...
Oct 2014 $ 1295
Kuwait Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Notwithstanding a recent escalation in political uncertainty, Kuwait's healthcare sector is forecast to preserve its trajectory of modest growth throughout the remainder of 2014. Rising sales are underpinned by an expanding popu...
Oct 2014 $ 1295
Iraq Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
The long-term prospects for the Iraqi pharmaceutical and healthcare markets remain promising given rising healthcare expenditure as well as further population growth. The Iraqi government has reportedly pledged to invest USD12bn into heal...
Oct 2014 $ 1295
United States - Pain Management Therapeutics Patients & Market Analysis
By Renub Research
Pain management is one of the fast growing medical disciplines that reduce chronic pain. Chronic pain afflicts a large population in the United States. The United States pain management therapeutics market has huge potential for growth due to the ...
Oct 2014 $ 1200
OTC Pharmaceuticals: Top 5 Emerging Markets Industry Guide
By MarketLine
Introduction The Emerging 5 OTC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The guide also c...
Oct 2014 $ 995
OTC Pharmaceuticals: Global Group of Eight (G8) Industry Guide
By MarketLine
Introduction The G8 OTC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The guide also contains ...
Oct 2014 $ 1495
Vietnam Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: The attractiveness of Vietnam's pharmaceutical market is steadily increasing. While structural challenges remain, such as the country's increasingly ageing population and under-capacity in terms of healthcare infrastructure and ...
Oct 2014 $ 1295
Ukraine Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Ukraine is currently experiencing geopolitical tension with its neighbour Russia, which is actively fomenting unrest in the east of Ukraine. In 2014, owing to the severe devaluation of the hryvnia in the country, drugmakers can ...
Oct 2014 $ 1295
Spain Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Despite the Spanish economy returning to growth in 2014 and picking up steam heading into 2015, we believe that the country's pharmaceutical sector will not follow suit until 2018. Regardless of calls made by companies for the i...
Oct 2014 $ 1295
Slovakia Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: The Slovakian health ministry has introduced orders to reign in medical fees charged by doctors and outpatient physician, with rules set to enter effect from autumn this year. Medical fees by hospitals and doctors are symptomati...
Oct 2014 $ 1295
Saudi Arabia Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: Saudi Arabia's economic, demographic, epidemiological and political factors will shape the provision of healthcare across the nation. Healthcare spending will be greatly boosted by government initiatives. The new health projects...
Oct 2014 $ 1295
Norway Pharmaceuticals and Healthcare Report Q4 2014
By Business Monitor International
BMI View: While the Norwegian government's pro-generic stance will continue to support growth in the country's off-patent medicines market, we highlight that the loss of market value in the patented drugs sector will not translate into an...
Oct 2014 $ 1295
Live Chat
Live Chat by Comm100